Invista 50 mg Tablet | 10 Tablets in 1 Strip

Introduction of Invista 50 mg Tablet

Invista 50 mg Tablet is an anti-cancer medicine containing Dasatinib as an active ingredient. Invista 50 mg Tablet is used to treat certain types of cancer. Especially Invista 50 mg Tablet is used to treat chronic myeloid leukaemia (CML),(a type of blood cancer that affects the production of white blood cells.) and also used to treat acute lymphoblastic leukaemia (ALL),( a type of cancer that affects the production of white blood cells in the bone marrow. Invista 50 mg Tablet belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the action of certain proteins that promote the growth and spread of cancer cells.

Invista 50 mg Tablet may cause some adverse effects may include nausea, vomiting, diarrhoea, fatigue, muscle and joint pain, and swelling in the hands and feet. More serious side effects, such as bleeding or blood clotting problems, can also occur. Your doctor might check your blood pressure regularly. It is advised to avoid antacid intake within 2 hours of taking this medicine. Invista 50 mg Tablet may reduce the number of blood cells in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells. It is important to talk to your doctor about the potential risks and benefits of taking Invista 50 mg.

Before using Invista 50 mg Tablet, inform your doctor if you have any pre-existing disease such as liver or kidney, weakened immune system, bleeding or blood clot problems, heart disease or low potassium and magnesium levels in the blood, and lung disease or any other medical complications. Additionally inform your doctor if you are using any prescription or non-prescription medicines, herbal, vitamins or any other medicines are using please make inform your doctor before taking this Invista 50 mg Tablet. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. Invista 50 mg Tablet is not recommended during pregnancy or while breastfeeding. You must avoid driving if you experience dizziness or blurred vision during treatment.

Invista 50 mg Tablet can be taken with or without food. It is best to take the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Invista 50 mg Tablet is not recommended for use in children and adolescents less than 18 years of age, because safety and efficacy have not been clinically established.

Uses of Invista 50 mg Tablet

Chronic myeloid leukaemia (CML): Invista 50 mg Tablet is used in the treatment of chronic myeloid leukaemia (CML), is a type of cancer that affects the blood and bone marrow, characterized by symptoms that may include fatigue, weakness, night sweats, weight loss, bone pain, and an enlarged spleen.

Acute lymphoblastic leukaemia (ALL): Invista 50 mg Tablet is used in the treatment of acute lymphoblastic leukaemia (ALL), a type of cancer that affects white blood cells. It is fast growing cancer that starts in the bone marrow, characterized by symptoms that may include fatigue, weakness, shortness of breath, easy bruising or bleeding, and frequent infections.

Benefits of Invista 50 mg Tablet

Invista 50 mg Tablet is effective and has a high rate of response in people with Chronic myeloid leukaemia (CML) and Acute lymphoblastic leukaemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL.

Invista 50 mg Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments.

Invista 50 mg is effective in people with CML or ALL who have not responded to other treatments.

Side Effects of Invista 50 mg Tablet

Invista 50 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects of Invista 50 mg Tablet

• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
  

Common Side Effects of Invista 50 mg Tablet

• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
  

How to Use Invista 50 mg Tablet?

Invista 50 mg Tablet may take with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

How Invista 50 mg Tablet Works?

Invista 50 mg Tablet belongs to a class of drugs called tyrosine kinase inhibitors, Invista 50 mg Tablet works by inhibiting the activity of specific proteins called tyrosine kinases, which play a role in the growth and survival of cancer cells. It inhibits the activity of the BCR-ABL tyrosine kinase, which is a key driver of the abnormal growth of CML and Ph+ ALL cells. By inhibiting the activity of the BCR-ABL tyrosine kinase, Invista 50 mg can help to slow down or stop the growth and spread of cancer cells, leading to an improvement in symptoms and potential benefits.

Safety Advices Invista 50 mg Tablet

Kidney

Use with Caution

Breastfeeding

Unsafe

Driving

Unsafe

Pregnancy

Unsafe

Alcohol

Unsafe

Liver

Use with Caution

References

1. Sprycel (dasatinib) Tablets, For Oral Use, Bristol-Myers Squibb Company, Princeton, USA, Product Leaflet 

2. Low-dose Dasatinib 50 Mg/day Versus Standard-dose Dasatinib 100 Mg/day As Frontline Therapy In Chronic Myeloid Leukemia In Chronic Phase: A Propensity Score Analysis, Author-koji Sasaki, Available Form 

3. Sprycel, (dasatinib) Tablet For Oral Use, Available Form 

4. Long-term Follow-up Of Lower Dose Dasatinib (50 Mg Daily) As Frontline Therapy In Newly Diagnosed Chronic-phase Chronic Myeloid Leukemia, National Libray Of Medicine. Nih, Available Form 

5. Dasatinib Tablet, Swords Laboratories Unlimited Company T/a Lawrence Laboratories , Product Monograph